The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,560.00
Bid: 4,560.00
Ask: 4,680.00
Change: 110.00 (2.44%)
Spread: 120.00 (2.632%)
Open: 4,540.00
High: 4,660.00
Low: 4,540.00
Prev. Close: 4,510.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

3 Jun 2021 12:00

RNS Number : 7270A
Camellia PLC
03 June 2021
 

3 June 2021

AGM Trading Statement

Camellia Plc (the "Company")

Camellia Plc (CAM.L) has today issued the following update on trading in the year to date.

Trading

Agriculture We are pleased that, despite the pandemic, all of our agricultural operations continue to operate. However, the Covid situation in India remains deeply concerning despite the extensive efforts made locally to keep all our staff safe, including restricting workforce deployment to 50% in West Bengal. Very dry conditions across northern India and Bangladesh to date have also resulted in reduced production which in turn has led to improved prices over the same period last year. However, following the recent elections, wage increases in Assam (backdated to 23 February 2021) have been agreed at 22.75% which is substantially more than the industry was anticipating. Productivity improvements and other cost reduction measures are being explored but the benefit of these may not arise until next year. As a result, the combined impact is a reduction in operating profits in 2021 of approximately £1 million. In Bangladesh there is now some indication that demand may be adversely impacted due to continuing Covid restrictions and this is expected to result in some pricing pressure in the coming months. In Kenya, whilst not quite at 2020's record levels, benign weather is resulting in very high volumes of tea and consequent weakness in auction prices which remain marginally behind 2020. In Malawi, both tea volumes and prices are ahead of 2020 as previously reported.

The harvest for our Hass avocado crop has started, with early indications that volumes will be up on last year but that pricing may be under pressure in what is anticipated to be a well supplied summer market in Europe.

Our macadamia operations continue to harvest and process their production with volumes expected to be higher than last year although as previously indicated, in Malawi pest damage has been experienced and indications are that this is more extensive than previously expected. The kernel market is active with both demand and prices improving.

Our remaining agricultural businesses are trading well, with our farming operation in Brazil seeing very high soya yields being sold into a strong market.

Non-agriculture Our non-agriculture businesses in the UK have had a difficult start to the year with the continuing restrictions hitting retail and food service. We are optimistic that as the restrictions continue to ease, trading in these businesses will improve. Aerospace also remains very quiet and we now anticipate no improvement in performance for the remainder of the year. 

Outlook

Whilst there are signs that normality is returning in some regions, the speed and intensity at which the pandemic has re-emerged in India demonstrates the need for continued vigilance. We have a very strong financial position and believe that over the long-term demand for our agricultural produce will continue to rise. As always, our financial results remain largely dependent on Agriculture where the majority of harvesting, and hence sales, takes place in the second half of the year. It is therefore too early to give a firm indication of the likely results for 2021 however the factors discussed above suggest the results for the year will be approximately £2 million below market expectations.

The Board of Camellia is also very much aware of the recent share price performance, which it believes is largely driven by the weakness in tea prices globally. Whilst there is little we can do regarding the tea price, a programme is being undertaken to review all non-core investments and other options with a view to maximising value for the Group and reducing UK costs. Additional detail will be issued in due course and as appropriate.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

Camellia Plc

Tom Franks, CEO

Susan Walker, CFO

 

01622 746655

Panmure Gordon

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

020 7886 2500

Maitland/AMO

PR

William Clutterbuck

 

 

07785 292617

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFIFSTRAIVIIL
Date   Source Headline
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update
6th Sep 20222:45 pmRNSInterim Report 2022 - Replacement
1st Sep 20224:00 pmRNSInterim Report 2022
1st Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSTrading Update
1st Jul 202210:54 amRNSResults of Annual General Meeting - 30 June 2022
30th Jun 20227:00 amRNSBF&M Strategic Review
30th Jun 20227:00 amRNSAGM Trading Statement
9th Jun 202211:12 amRNSBoard Committee Changes
6th Jun 20225:22 pmRNSAnnual Report and Notice of AGM
31st May 20227:00 amRNSFinal Results
6th May 20227:00 amRNSDirector Changes and Trading Update
22nd Dec 20217:00 amRNSTrading Update
17th Nov 20217:00 amRNS100% Ownership of Bardsley England
2nd Nov 20217:00 amRNSDirectorate Change
2nd Sep 20212:36 pmRNSInterim Report 2021
2nd Sep 20217:00 amRNSHalf-year Report and changes to Board Committees
25th Aug 202112:42 pmRNSNotice of Interim Results
6th Aug 20218:30 amRNSDeath of Director
5th Aug 20217:00 amRNSSale of Abbey Metal Finishing
2nd Aug 20217:00 amRNSPurchase of Bardsley England
20th Jul 20212:00 pmRNSTrading Update
3rd Jun 20214:15 pmRNSResults of Annual General Meeting - 3 June 2021
3rd Jun 202112:00 pmRNSAGM Trading Statement
5th May 20214:00 pmRNSAnnual Report and Notice of AGM
4th May 20217:00 amRNSFinal Results and Directorate change
29th Apr 20214:30 pmRNSFinal Results - Date of Announcement
11th Feb 20218:00 amRNSTrading update and settlement of claims
16th Nov 20207:00 amRNSCompletion of asset disposal
2nd Nov 20207:15 amRNSGovernance changes
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.